Elevated fasting and postload glucose concentrations: Risk factors for developing type-2 diabetes mellitus; results of the Hoorn study;Verhoogde glucoseconcentraties in nuchtere toestand en na glucosebelasting: Risicofactoren van het ontstaan van diabetes mellitus type 2; resultaten van de Hoorn-studie

Nederlands Tijdschrift voor Geneeskunde

Volumn 147, Issue 29, 2003, Pages 1414-1418

  De Vegt, F ^a   Dekker, J M ^b   Jager, A ^b   Hienkens, E ^b   Kostense, P J ^b   Stehouwer, C D A ^c   Nijpels, G ^c   Bouter, L M ^b   Heine, R J ^c  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; COHORT ANALYSIS; DIET RESTRICTION; DISEASE PREDISPOSITION; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; GLUCOSE TOLERANCE TEST; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PROSPECTIVE STUDY; RISK FACTOR;

EID: 0038158883     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 1998;21:1414-31.
2. Klein R. Hyperglycemia and microvascular and macrovascular disease in diabetes. Diabetes Care 1995;18:258-68.
3. Laakso M. Hyperglycemia and cardiovascular disease in type 2 diabetes. Diabetes 1999;48:937-42.
4. Sinclair AJ, Robert IE, Croxson SC. Mortality in older people with diabetes mellitus. Diabet Med 1997;14:639-47.
5. Haffner SM, Miettinen H, Stern MP. Are risk factors for conversion to NIDDM similar in high and low risk populations? Diabetologia 1997;40:62-6.
6. Marshall JA, Hoag S, Shetterly S, Hamman RF. Dietary fat predicts conversion from impaired glucose tolerance to NIDDM. The San Luis Valley Diabetes Study. Diabetes Care 1994;17:50-6.
7. Motala AA, Omar MA, Gouws E. High risk of progression to NIDDM in South-African Indians with impaired glucose tolerance. Diabetes 1993;42:556-63.
8. Nijpels G. Determinants for the progression from impaired glucose tolerance to non-insulin-dependent diabetes mellitus. Eur J Clin Invest 1998;28(Suppl 2):8-13.
9. Harris MI. Impaired glucose tolerance - prevalence and conversion to NIDDM. Diabet Med 1996;13(3 Suppl 2):S9-11.
10. Warram JH, Sigal RJ, Martin BC, Krolewski AS, Soeldner JS. Natural history of impaired glucose tolerance: follow-up at Joslin Clinic. Diabet Med 1996;13(9 Suppl 6):S40-5.
11. Edelstein SL, Knowler WC, Bain RP, Andres R, Barrett-Connor EL, Dowse GK, et al. Predictors of progression from impaired glucose tolerance to NIDDM. Diabetes 1997;46:701-10.
12. Chou P, Li CL, Wu GS, Tsai ST. Progression to type 2 diabetes among high-risk groups in Kin-Chen, Kinmen. Exploring the natural history of type 2 diabetes. Diabetes Care 1998;21:1183-7.
13. Dinneen SF, Maldonado 3rd D, Leibson CL, Klee GG, Li H, Melton 3rd LJ, et al. Effects of changing diagnostic criteria on the risk of developing diabetes. Diabetes Care 1998;21:408-13.
14. Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 1997;20:537-44.
15. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997;20:1183-97.
16. World Health Organization (WHO). Diabetes mellitus. Report of a WHO Study Group. Technical Report Series nr 727. Genève: WHO; 1985.
17. World Health Organization (WHO). Definition, diagnosis and classification of diabetes mellitus. Report of a WHO consultation. Part I. Diagnosis and classification of diabetes mellitus. Genève: WHO; 1999.
18. Mooy JM, Grootenhuis PA, Vries H de, Valkenburg HA, Bouter LM, Kostense PJ, et al. Prevalence and determinants of glucose intolerance in a Dutch caucasian population. The Hoorn Study. Diabetes Care 1995;18:1270-3.
19. Mooy JM, Grootenhuis PA, Vries H de, Kostense PJ, Popp-Snijders C, Bouter LM, et al. Intra-individual variation of glucose, specific insulin and proinsulin concentrations measured by two oral glucose tolerance tests in a general Caucasian population: the Hoorn Study. Diabetologia 1996;39:298-305.
20. Feskens EJ, Bowles CH, Kromhout D. Intra- and interindividual variability of glucose tolerance in an elderly population. J Clin Epidemiol 1991;44:947-53.
21. Vegt F de, Dekker JM, Stehouwer CDA, Nijpels G, Bouter LM, Heine RJ. Similar 9-year mortality risks and reproducibility for the World Health Organization and American Diabetes Association glucose tolerance categories: the Hoorn Study. Diabetes Care 2000;23:40-4.
22. Nijpels G, Popp-Snijders C, Kostense PJ, Bouter LM, Heine RJ. Fasting proinsulin and 2-h post-load glucose levels predict the conversion to NIDDM in subjects with impaired glucose tolerance: the Hoorn Study. Diabetologia 1996;39:113-8.
23. Shaw JE, Zimmet PZ, de Courten M, Dowse GK, Chitson P, Gareeboo H, et al. Impaired fasting glucose or impaired glucose tolerance. What best predicts future diabetes in Mauritius? Diabetes Care 1999;22:399-402.
24. Vaccaro O, Ruffa G, Imperatore G, Iovino V, Rivellese AA, Riccardi G. Risk of diabetes in the new diagnostic category of impaired fasting glucose. Diabetes Care 1999;22:1490-3.
25. DeFronzo RA. Pharmacologic therapy for type 2 diabetes mellitus. Ann Intern Med 1999;131:281-303.
26. Alberti KG. The clinical implications of impaired glucose tolerance. Diabet Med 1996;13:927-37.